Search Results - "Zeng, Yunli"
-
1
Cutoff value of IC50 for drug sensitivity in patient-derived tumor organoids in colorectal cancer
Published in iScience (21-07-2023)“…Patient-derived tumor organoids (PDTOs) have the potential to be used to predict the patient response to chemotherapy. However, the cutoff value of the…”
Get full text
Journal Article -
2
Use of patient-derived tumor organoid platform to predict the benefit of postoperative adjuvant chemotherapy for poor responders to neoadjuvant chemoradiotherapy in locally advanced rectal cancer
Published in Bioengineering & translational medicine (01-11-2023)“…Postoperative adjuvant chemotherapy (AC) for poor responders to neoadjuvant chemoradiotherapy (nCRT) remains debatable among patients with locally advanced…”
Get full text
Journal Article -
3
Patient-Derived Tumor Organoids Can Predict the Progression-Free Survival of Patients With Stage IV Colorectal Cancer After Surgery
Published in Diseases of the colon & rectum (01-05-2023)“…Recent studies have shown patient-derived tumor organoids can predict the drug response of patients with cancer. However, the prognostic value of…”
Get full text
Journal Article -
4
Patient-Derived Tumor Organoids Can Predict the Progression-Free Survival of Stage IV Colorectal Cancer Patients After Surgery
Published in Diseases of the colon & rectum (09-03-2023)Get full text
Journal Article -
5
Cutoff value of IC 50 for drug sensitivity in patient-derived tumor organoids in colorectal cancer
Published in iScience (21-07-2023)“…Patient-derived tumor organoids (PDTOs) have the potential to be used to predict the patient response to chemotherapy. However, the cutoff value of the…”
Get full text
Journal Article